Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |